R-108

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameR-108
Drug Alias NameR-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor antagonistsProstanoid EP2 receptor antagonists
TargetsProstanoid EP4 receptorProstanoid EP2 receptor
Therapy Area/IndicationsAdenomatous Polyposis ColiNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioseek Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioseek Llc
Active IndicationsN/A
Inactive IndicationsAdenomatous Polyposis ColiNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A